Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA issues complete response letter regarding Cempra's NDAs for solithromycin

Dec. 30, 2016

EILV as an affordable and efficient alphavirus vaccine platform against chikungunya fever

Dec. 30, 2016

Shire is enrolling patients in phase III trial of maribavir in transplant recipients

Dec. 29, 2016

Achillion Pharmaceuticals receives milestone payment for JNJ-4178

Dec. 29, 2016

DynPort Vaccine Company receives contract to help advance medical products for NIAID

Dec. 28, 2016

Ebola vaccine rVSV-ZEBOV shows promising results in clinical trial

Dec. 28, 2016

GlaxoSmithKline and University of Dundee describe antiparasitic agents

Dec. 27, 2016

Benitec Biopharma announces progress in ddRNAi program for HBV

Dec. 23, 2016

Inovio Pharmaceuticals reports positive results from first human study of Zika vaccine

Dec. 22, 2016

Preliminary phase I data for Viralym-C in patients with refractory CMV infection

Dec. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...